III. THE FATE OF CITRATE IN ERYTHROBLASTOTIC INFANTS TREATED WITH EXCHANGE TRANSFUSION 12
Open Access
- 1 May 1949
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 28 (3) , 474-481
- https://doi.org/10.1172/jci102093
Abstract
Exchange transfusions were carried out on one mongoloid newborn with no symptoms of liver damage or erythroblastosis and on 8 newborns with erythroblastosis fetalis. Serial studies done on blood removed from these infants indicated that the citrate contained in the added blood was rapidly metabolized by the infant. Admn. of Ca gluconate interferes with the rate of citrate removal from the blood stream. Endogenous Ca levels were observed to rise on the addition of citrated blood. Total base, citrate, P, Ca and total protein levels were normal 1 hr. after the completion of the transfusion. Erythroblastotic infants showed impaired ability to remove citrate as compared to the infant with no liver damage. The liver, kidneys, musculature and bone appear to remove or neutralize the effect of high citrate levels in the blood stream.This publication has 7 references indexed in Scilit:
- RESULTS OF THERAPY OF ERYTHROBLASTOSIS WITH EXCHANGE TRANSFUSIONBlood, 1949
- MICROESTIMATION OF CITRIC ACID; A NEW COLORIMETRIC REACTION FOR PENTABROMOACETONEJournal of Biological Chemistry, 1948
- Massive Necrosis of Liver Following Exchange Transfusion for Erythroblastosis FetalisAmerican Journal of Clinical Pathology, 1948
- THERAPY OF ERYTHROBLASTOSIS FETALIS WITH EXCHANGE TRANSFUSION1947
- SUBSTITUTION TRANSFUSION: A NEW TREATMENT FOR SEVERE ERYTHROBLASTOSIS FETALISArchives of Pediatrics & Adolescent Medicine, 1947
- THE USE OF HEPARIN WHEN PERFORMING EXCHANGE BLOOD TRANSFUSIONS IN NEWBORN INFANTS1946
- On the Toxicity of Hydroxyacetic Acid After Prolonged Administration: Comparison With Its Sodium Salt and Citric and Tartaric Acids*†Journal of the American Pharmaceutical Association (Scientific ed.), 1945